Neumora Therapeutics, Inc. (NMRA)
NASDAQ: NMRA · Real-Time Price · USD
10.85
+0.35 (3.33%)
At close: Dec 20, 2024, 4:00 PM
10.36
-0.49 (-4.52%)
After-hours: Dec 20, 2024, 6:32 PM EST
Neumora Therapeutics Employees
Neumora Therapeutics had 124 employees as of December 31, 2023. The number of employees increased by 30 or 31.91% compared to the previous year.
Employees
124
Change (1Y)
30
Growth (1Y)
31.91%
Revenue / Employee
n/a
Profits / Employee
-$2,368,532
Market Cap
1.75B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 124 | 30 | 31.91% |
| Dec 31, 2022 | 94 | 6 | 6.82% |
| Dec 31, 2021 | 88 | 35 | 66.04% |
| Dec 31, 2020 | 53 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 18,000 |
| National HealthCare | 13,123 |
| Amphastar Pharmaceuticals | 1,761 |
| Certara | 1,391 |
| Galapagos NV | 1,123 |
| ImmunityBio | 628 |
| Recursion Pharmaceuticals | 500 |
| MannKind | 414 |
NMRA News
- 5 weeks ago - This biotech's stock could double if its treatment for major depressive disorder succeeds, says Mizuho - Market Watch
- 5 weeks ago - Neumora Therapeutics, Inc. (NMRA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Neumora Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 6 weeks ago - Neumora Therapeutics to Participate in Upcoming Conferences in November - GlobeNewsWire
- 4 months ago - Neumora Therapeutics to Host Key Opinion Leader Roundtable to Discuss the Potential of Navacaprant in Neuropsychiatric Disorders - GlobeNewsWire
- 6 months ago - Neumora Therapeutics Announces Initiation of Phase 1b Study of NMRA-511 for Treatment of Alzheimer's Disease Agitation - GlobeNewsWire
- 7 months ago - Neumora Therapeutics Announces Initiation of Phase 2 Study of Navacaprant in Bipolar Depression - GlobeNewsWire
- 8 months ago - Neumora Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire